首页> 美国卫生研究院文献>Journal of Crohns Colitis >Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

【2h】

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

机译：托法替尼治疗溃疡性结肠炎：3期随机对照诱导和维持研究中与健康相关的生活质量

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and AimsTofacitinib is an oral, small molecule Janus kinase [JAK] inhibitor that is being investigated for ulcerative colitis [UC]. We evaluated health-related quality of life [HRQoL] in tofacitinib UC Phase 3 studies.

机译：背景和目的Tofacitinib是一种口服小分子Janus激酶[JAK]抑制剂，正在研究其用于溃疡性结肠炎[UC]。我们在tofacitinib UC 3期研究中评估了健康相关的生活质量[HRQoL]。

著录项

期刊名称 Journal of Crohns Colitis
作者
Julian Panés; Séverine Vermeire; James O Lindsay; Bruce E Sands; Chinyu Su; Gary Friedman; Haiying Zhang; Aaron Yarlas; Martha Bayliss; Stephen Maher; Joseph C Cappelleri; Andrew G Bushmakin; David T Rubin;
展开▼
作者单位

展开▼
年(卷),期 -1(12),2
年度 -1
页码 145–156
总页数 12
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Patient-reported outcomes quality of life ulcerative colitis;

机译：患者报告的结果;生活质量;溃疡性结肠炎;

相似文献

外文文献
中文文献
专利

1. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies (vol 24, pg 145, 2018) [J] . Panes Julian, Vermeire Severine, Lindsay James O., Journal of Crohn’s & colitis . 2019,第1期

机译：患有溃疡性结肠炎患者的Tofacitinib：3期随机对照诱导和维护研究中的健康相关生活质量（Vol 24，PG 145,2018）
2. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies [J] . Panes Julian, Vermeire Severine, Lindsay James O., Journal of Crohn’s & colitis . 2018,第2期

机译：患有溃疡性结肠炎患者的TOFACITINIB：3期随机对照诱导和维护研究中的健康状生活质量
3. Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studies [J] . Motoya Satoshi, Watanabe Mamoru, Kim Hyo Jong, Intestinal research. . 2018,第2期

机译：东亚活动性溃疡性结肠炎患者的Tofacitinib诱导和维持治疗：来自三项三期跨国研究的亚组分析
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Quality of life of patients with mucosal ulcerative colitis following ileal pouch anal anastomosis surgery. [D] . Quinn Griffin, Mary Therese. 2001

机译：回肠袋肛门吻合手术后粘膜溃疡性结肠炎患者的生活质量。
6. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies [O] . Julian Panés, Séverine Vermeire, James O Lindsay, -1

机译：托法替尼治疗溃疡性结肠炎：3期随机对照诱导和维持研究中与健康相关的生活质量
7. Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies [O] . Julian Panés, Séverine Vermeire, James O Lindsay, 2018

机译：患有溃疡性结肠炎患者的TOFACITINIB：3期随机控制诱导和维护研究中的健康状生活质量

Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies

摘要

著录项

相似文献

相关主题

期刊订阅